SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe
Clinical trial NCT00402272 · COMPLETED
Trial details
- NCT number
- NCT00402272
- Sponsor
- Abbott Medical Devices
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-02-01
- Enrollment
- 2700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.